反応式
[N:1]([C@@H:4]1[CH2:12][C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[C@H:5]1[NH:13][C:14]1[C:19]([CH:20]2[CH2:22][CH2:21]2)=[N:18][C:17]([C:23]2[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][C:24]=2[Cl:30])=[C:16]([CH:31]2[CH2:33][CH2:32]2)[N:15]=1)=[N+]=[N-].C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.O>C1COCC1>[CH:20]1([C:19]2[C:14]([NH:13][C@@H:5]3[C:6]4[C:11](=[CH:10][CH:9]=[CH:8][CH:7]=4)[CH2:12][C@H:4]3[NH2:1])=[N:15][C:16]([CH:31]3[CH2:32][CH2:33]3)=[C:17]([C:23]3[CH:28]=[CH:27][C:26]([Cl:29])=[CH:25][C:24]=3[Cl:30])[N:18]=2)[CH2:21][CH2:22]1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of N-[(1R,2R)-2-azido-2,3-dihydro-1H-inden-1-yl]-3,6-dicyclopropyl-5-(2,4-dichlorophenyl)pyrazin-2-amine (0.55 g, 1.15 mmol) in anhydrous THF (30 mL) was added PPh3 (0.396 g, 1.51 mmol). The resulting mixture was stirred at rt for 3 hr. To the solution was added water (0.25 mL, 13.9 mmol). The reaction is then allowed to stir overnight at rt. The mixture is concentrated, and the resulting solid is dissolved in MeOH. Purify by passage over Biorad acidic resin by applying the MeOH solution onto the resin and rinsing the resin with MeOH. The resin was then rinsed with 5% triethylamine/MeOH solution to afford 0.52 g (75%) of (1R,2R)-N1-[3,6-dicyclopropyl-5-(2,4-dichlorophenyl)pyrazin-2-yl]-2,3-dihydro-1H-indene-1,2-diamine as a solid: 1H NMR (CDCl3) δ 0.85-1.12, 1.64-1.76, 1.89, 2.68-2.82, 3.31-3.39, 3.66-3.72, 5.16, 5.33, 7.28-7.53; MS (ESI+) for C25H24Cl2N4 m/z 451 (M+H)+.
後処理
- stirringto stir overnight at rt
- concentrationThe mixture is concentrated
- dissolutionthe resulting solid is dissolved in MeOH
- customPurify by passage over Biorad acidic resin
- washrinsing the resin with MeOH
- washThe resin was then rinsed with 5% triethylamine/MeOH solution
出典と根拠
- ORDレコード
- ord-f23a97bae0e24791abe92ce475928c21
- 出典データセット
- uspto-grants-2006_01
- 特許番号
- US06992087B2
関連ノート
読み込み中…